Maravai Lifesciences Holdings Inc (MRVI) — Financial Flexibility Index
Maravai Lifesciences Holdings Inc (MRVI) has a Financial Flexibility Index of 0.02x as of June 2026. Free cash flow of $4.36 Million (operating CF $3.99 Million minus capex $370.00K) represents 0% of total liabilities ($248.16 Million). Check cash flow reinvestment rate of Maravai Lifesciences Holdings Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Maravai Lifesciences Holdings Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Maravai Lifesciences Holdings Inc across 8 annual periods. For the full cash flow conversion analysis, see Maravai Lifesciences Holdings Inc cash flow conversion.
Annual Financial Flexibility Index for Maravai Lifesciences Holdings Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Maravai Lifesciences Holdings Inc. Explore MRVI cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.11x | $-44.42 Million | $-57.57 Million | $397.87 Million | ▼ -229.6% |
| 2024 | 0.09x | $37.12 Million | $7.46 Million | $431.04 Million | ▼ -68.7% |
| 2023 | 0.27x | $191.78 Million | $126.22 Million | $697.57 Million | ▼ -31.5% |
| 2022 | 0.40x | $553.07 Million | $535.98 Million | $1.38 Billion | ▲ +43.8% |
| 2021 | 0.28x | $383.42 Million | $368.57 Million | $1.37 Billion | ▲ +75.5% |
| 2020 | 0.16x | $177.59 Million | $152.19 Million | $1.12 Billion | ▲ +67.1% |
| 2019 | 0.10x | $41.26 Million | $24.11 Million | $433.17 Million | ▲ +989.3% |
| 2018 | 0.01x | $3.42 Million | $-186.00K | $391.66 Million | — |